A high-dose statin therapy for a post-acute coronary syndrome patient appears to produce no higher risk of kidney injury than a low-dose regimen. Study findings may reassure clinicians that high-potency statins are safe for patients after ACS. MedPage Today reports:
For post-acute coronary syndrome patients, high-dose statin therapy appeared to produce no higher a risk of kidney injury than a low-dose regimen, according to preliminary subanalyses of two randomized trials.
There were no differences between patients taking either 40 or 80 mg of a statin in creatinine elevations of >1.5, >2.0, and >3.0 mg/dL in the PROVE IT-TIMI 22 randomized trial, according to Amy Sarma, MD, MHS, of Brigham and Women's Hospital in Boston, and colleagues.
Similarly, in the A-to-Z Trial, researchers found no statistical differences in creatinine elevation at the same three increased levels between patients receiving 20 mg or 40 mg of statin therapy, Sarma reported during the American Heart Association's Emerging Science Series webinar.
Read the full story here: http://bit.ly/12ep1os
Empowering Community Health Through Wellness and Faith
April 23rd 2024To help celebrate and recognize National Minority Health Month, we are bringing you a special month-long podcast series with our Strategic Alliance Partner, UPMC Health Plan. In the third episode, Camille Clarke-Smith, EdD, MS, CHES, CPT, discusses approaching community health holistically through spiritual and community engagement.
Listen
Data Back Neoadjuvant Combo vs Chemo Alone for Early-Stage NSCLC
April 24th 2024For patients with early-stage non–small cell lung cancer (NSCLC), combining neoadjuvant immune checkpoint inhibitors and platinum-based chemotherapy improves 2-year outcomes over chemotherapy alone, suggest findings of an extensive literature review and meta-analysis.
Read More
Overcoming Employment Barriers for Lasting Social Impact: Freedom House 2.0 and Pathways to Work
April 16th 2024To help celebrate and recognize National Minority Health Month, we are bringing you a special month-long podcast series with our Strategic Alliance Partner, UPMC Health Plan. Welcome to our second episode, in which we learn all about Freedom House 2.0 and the Pathways to Work program.
Listen
Patient Navigation in Oncology at Heart of Priority Health White House Visit
April 24th 2024On March 27, Priority Health's president and CEO, Praveen Thadani participated in a discussion on how to expand and optimize patient navigation services in oncology care, as part of the Cancer Moonshot initiative.
Read More